JS
Jaswinder Singh
About Jaswinder Singh
Data last updated:
Jaswinder Singh is a Director at Signoret Pharmaceuticals Private Limited (since 2020) and Director at Capcure Pharmaceuticals Private Limited (since 2019). The companies operate in Pharma. The largest current company by reported revenue is Signoret Pharmaceuticals Private Limited at ₹3.50 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Jun 2020 | 2019 | ₹3.50 Cr (FY 2025) | Active | |
| Director | 29 May 2019 | 2019 | Active |
Board colleagues of Jaswinder Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rajwinder Kaur | 08367198 | Signoret Pharmaceuticals Private Limited , Capcure Pharmaceuticals Private Limited | Director |
| Simranjeet Singh | 08367199 | Signoret Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jaswinder Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jaswinder Singh
Jaswinder Singh currently holds 2 directorships: Signoret Pharmaceuticals Private Limited (Director, since 12 Jun 2020, revenue ₹3.50 Cr (FY 2025)); Capcure Pharmaceuticals Private Limited (Director, since 29 May 2019).
Jaswinder Singh was first appointed on 29 May 2019 as Director at Capcure Pharmaceuticals Private Limited. The most recent appointment on record is 12 Jun 2020 at Signoret Pharmaceuticals Private Limited.
The current boards of Jaswinder Singh's companies include Rajwinder Kaur (Signoret Pharmaceuticals Private Limited), Simranjeet Singh (Signoret Pharmaceuticals Private Limited).